Owing to nucleocytoplasmic translocation of HuR being necessary for its activity and the cytoplasmic presence of HuR found in several carcinomas, it has been hypothesized that cytoplasmic HuR expression may be a prognostic marker in cancer patients (8,9). This evidence concerns the gene ELAVL1 and cancer.